380
Views
14
CrossRef citations to date
0
Altmetric
Research Article

In vitro genotoxic and cytotoxic effects of doxepin and escitalopram on human peripheral lymphocytes

, , &
Pages 238-244 | Received 13 Jan 2017, Accepted 05 Aug 2017, Published online: 31 Aug 2017

References

  • Arimochi, H. and Morita, K., 2006. Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. European Journal of Pharmacology, 541, 17–23.
  • Attia, S.M., Ashour, A.E., and Bakheet, S.A., 2013. Comet-FISH studies for evaluation of genetic damage of citalopram in somatic cells of the mouse. Journal of Applied Toxicology, 33, 901–905.
  • Attia, S.M. and Bakheet, S.A., 2013. Citalopram at the recommended human doses after long-term treatment is genotoxic for male germ cell. Food and Chemical Toxicology, 53, 281–285.
  • Battal, D., et al., 2013. In vivo genotoxicity assessment of sertraline by using alkalin comet assay and the cytokinesis-block micronucleus assay. Basic & Clinical Pharmacology & Toxicology, 113, 339–346.
  • Bozkurt, G., et al., 2004. Clastogenicity of selective serotonin-reuptake inhibitors. Mutation Research, 558, 137–144.
  • Collins, A.R., 2004. The comet assay for DNA damage and repair: principles, applications, and limitations. Molecular Biotechnology, 26, 249–261.
  • Cosgrove, L., et al., 2011. Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers’ financial associations with industry. PLoS One, 4 (6), 1–8.
  • Cotterchio, M., et al., 2000. Antidepressant medication use and breast cancer risk. American Journal of Epidemiology, 151 (10), 951–957.
  • Donbak, L., Dal, O., and Çelik, M., 2014. Genotoxıc effects of antıdepressant reboxetıne in human perıpheral lymphocytes. Advance Laboratory Medicine International, 4 (3), 93–102.
  • Draz, E.I., et al., 2009. Genotoxicity of some commonly used antidepressants (fluoxetıne, sertraline and clomipramine). Mansoura Journal of Forensic Medicine & Clinical Toxicology, 17 (2), 63–77.
  • Dusinska, M. and Collins, A.R., 2008. The comet assay in human biomonitoring: gene–environment interactions. Mutagenesis, 23 (3), 191–205.
  • Eastmond, D.A. and Tucker, J.D., 1989. Identification of aneuploidyinducing agents using cytokinesis-blocked human-lymphocyte sand an antikinetochore antibody. Environmental and Molecular Mutagenesis, 13, 34–43.
  • Environmental Protection Agency (EPA). 1996. Health effects test guidelines OPPTS 870.5900: in vitro sister chromatid exchanges (EPA 712-C-96-234). Washington, DC: EPA.
  • Fenech, M., 2000. The in vitro micronucleus technique. Mutation Research, 455, 81–95.
  • Fenech, M., et al., 2003. HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutation Research, 534, 65–75.
  • Fenech, M., 2007. Cytokinesis-block micronucleus cytome assay. Nature Protocols, 2 (5), 1084–1104.
  • Feng, S., et al., 2005. Assessing the genotoxicity of imidacloprid and RH-5849 in human peripheral blood lymphocytes in vitro with comet assay and cytogenetic tests. Ecotoxicology and Environmental Safety, 61, 239–246.
  • Ghaderi, F., et al., 2016. DSC kinetic study of the incompatibility of doxepin with dextrose. Journal of Thermal Analysis and Calorimetry, 123, 2081–2090.
  • Hassanane, M.S., et al., 2012. Genotoxic evaluation for the tricyclic antidepressant drug, amitriptyline. Drug and Chemical Toxicology, 35 (4), 450–455.
  • Kalweit, S., Vasudey, V., and Obe, G., 1988. Liquid-holding experiments with human lymphocytes. III. Experiments with G0 and G1 cells. Mutation Research, 207, 41–44.
  • Kirsch-Volders, M., et al., 2003. Report from the in vitro micronucleus assay working group. Mutation Research, 540, 153–163.
  • Kumaravel, T.S., et al., 2009. Comet assay measurements: a perspective. Cell Biology and Toxicology, 25, 53–64.
  • Lorge, E., et al., 2008. Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test I. Theoretical Aspects. Mutation Research, 655, 1–3.
  • Maluf, S.W. and Erdtmann, B., 2000. Follow-up study of the genetic damage in lymphocytes of pharmacists and nurses handling antineoplastic drugs evaluated by cytokinesis-block micronuclei analysis and single cell gel electrophoresis assay. Mutation Research, 471, 21–27.
  • Moorhead, P.S., et al., 1960. Chromosome preparations of leucocytes cultured from peripheral blood. Experimental Cell Research, 20, 613–616.
  • Norppa, H., et al., 2006. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutation Research, 600, 37–45.
  • Organisation for Economic Co-operation and Development, 1986. Genetic toxicology: in vitro sister chromatid exchange assay in mammalian cells. Paris: OECD.
  • Olfson, M. and Marcus, S.C., 2009. National patterns in antidepressant medication treatment. Archives of General Psychiatry, 66 (8), 848–856.
  • Perez, R.P., et al., 2002. Sister chromatid exchanges produced by imipramine and desipramine in mouse bone marrow cells treated in vivo. Toxicology Letters, 132, 123–129.
  • Perry, P. and Wolff, S., 1974. New Giemsa method for the differential staining of sister chromatids. Nature, 251, 156–158.
  • Roshdy, H.M. and Shoman, T.M.T., 2004. Cytogenetic and developmental effects of antidepression drug (Escitalopram) on female mice and embryos. The Egyptian Journal of Hospital Medicine, 17, 63–69.
  • Schaik, N.V. and Graf, U., 1991. Genotoxicity evaluation of five tricyclic antidepressants in the wing somatic mutation and recombination test in Drosophila melanogaster. Mutation Research, 260 (1), 99–104.
  • Schaik, N.V. and Graf, U., 1993. Structure-activity relationships of tricyclic antidepressants and related compounds in the wing somatic mutation and recombination test of Drosophila melanogaster. Mutation Research, 286 (2), 155–163.
  • Spina, E., Santoro, V., and D’Arrigo, C., 2008. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clinical Therapeutics, 30 (7), 1206–1227.
  • Steingart, A., et al., 2003. Antidepressant medication use and breast cancer risk: a case-control study. International Journal of Epidemiology, 32, 961–966.
  • Tamim, H., et al., 2006. Risk of breast cancer in association with exposure to two different groups of tricyclic antidepressants. Pharmacoepidemiology and Drug Safety, 15, 689–697.
  • Tazehkand, M.N. and Topaktas, M., 2015. The in vitro genotoxic and cytotoxic effects of remeron on human peripheral blood lymphocytes. Drug and Chemical Toxicology, 38 (3), 266–271.
  • Tice, R.R., et al., 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environmental and Molecular Mutagenesis, 35, 206–221.
  • Tucker, J.D. and Preston, R.J., 1996. Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment. Mutation Research, 365, 147–159.
  • Villarini, M., et al., 1998. In vitro genotoxic effects of the insecticide deltamethrin in human peripheral blood leukocytes: DNA damage (comet’ assay) in relation to the induction of sister-chromatid exchanges and micronuclei. Toxicology, 130, 129–139.
  • Wilson, D.M. and Thompson, L.H., 2007. Molecular mechanisms of sister-chromatid exchange. Mutation Research, 616, 11–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.